RecruitingNCT05441969

In Vivo Cortical Excitability Modulation in Major Depressive Disorder


Sponsor

Fundacao Champalimaud

Enrollment

90 participants

Start Date

May 19, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The pathophysiology of Major Depression Disorder (MDD) is unclear, with several theories for its neurobiological mechanisms. One possible explanation is the presence of altered neuroplasticity, which can be studied by Transcranial Magnetic Stimulation (TMS). Using TMS to study these mechanisms is performed by applying electromagnetic stimuli to the motor cortex, to obtain measures of temporary cortical excitability modulation. It is known that depressed patients with higher cortical modulation are more responsive to a TMS treatment course. However, it is unknown if there are differences in cortical modulation between depressed patients and healthy subjects. Our goal is to answer this question and contribute towards clarification of the neuroplasticity mechanisms underlying MDD. Accordingly, the investigators will access cortical excitability modulation measures in both depressed patients and healthy volunteers and compare their results. The investigators will also re-assess these measures after 6 weeks of antidepressant treatment. Finally, the investigators will study the association between cortical excitability measures and cognitive processes using an innovative cognitive task.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria1

  • \. Diagnosis of major depressive episode or disorder as provided in the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5) (American Psychiatric Association. 2013).

Exclusion Criteria13

  • Moderate to severe suicide risk;
  • Known personal history of bipolar disorder or psychotic disorder;
  • Alcohol or other substance abuse and/or dependence;
  • Developmental disorder;
  • Dementia;
  • Presence of uncontrolled active medical illness;
  • Known structural lesion of the central nervous system;
  • Electrical or metallic brain implants;
  • Cardiac implants;
  • Epilepsy;
  • Active use of medication known to cause seizures;
  • Pregnancy;
  • Breastfeeding.

Interventions

OTHERNo intervention/expousure

No interventions/expousure since this is an observational study.


Locations(1)

Champalimaud Foundation

Lisbon, Portugal

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05441969


Related Trials